MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
Miltenyi Biomedicine GmbH
Miltenyi Biomedicine GmbH
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center
University of Virginia
Seagen Inc.
Dana-Farber Cancer Institute
Pfizer
City of Hope Medical Center
iOnctura
BeOne Medicines
AbbVie
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
C4 Therapeutics, Inc.
Hackensack Meridian Health
Ohio State University Comprehensive Cancer Center
Baylor College of Medicine
Fred Hutchinson Cancer Center
University of Florida
Fate Therapeutics
Cellectar Biosciences, Inc.
Novartis
BeOne Medicines
Memorial Sloan Kettering Cancer Center
Innovent Biologics (Suzhou) Co. Ltd.
Eli Lilly and Company
Case Comprehensive Cancer Center
Taiho Oncology, Inc.
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
PeproMene Bio, Inc.
Washington University School of Medicine
Baylor College of Medicine